Revealed: 5-Star Employers of Choice 2024

Congratulations to all of this year's winners from HRD Asia

Revealed: 5-Star Employers of Choice 2024

HRD Asia is excited to reveal the 5-Star Employer of Choice 2024 list, which celebrates employers that are redefining what it means to be a “top employer.”

The Special Report recognises companies that go above and beyond for their employees, specifically in the areas of benefits, compensation, culture, employee development, and diversity and inclusion.

Employers that were recognised for their stellar efforts this year focused on empowering employees, continually measuring culture and monitoring industry trends.

The 2024 winners of the 5-Star Employer of Choice include:

To see the full list of winners and read the 5-Star Employer of Choice Special Report, click here.

Methodology

The entry process for HRD Asia’s 2024 5-Star Employer of Choice comprised two steps: an employer submission followed by an employee survey.

First, organisations had to complete an in-depth submission to explain their various offerings and practices. Next, employees from nominated organisations were asked to fill out an anonymous form evaluating their workplace on a number of metrics, including benefits, compensation, culture, employee development, and commitment to diversity and inclusion.
To be considered, each organisation had to reach a minimum number of employee responses based on overall size. Organisations that achieved a 75% or greater average satisfaction rating from employees were named 5-Star Employers of Choice for 2024.

Recent articles & video

Terminated employee deletes employer's virtual systems: reports

'AI is not the endgame': report

Wells Fargo employees fired for 'simulation of keyboard activity'

Tesla shareholders approve Musk's $48-billion compensation package

Most Read Articles

Best employers in Asia announced: HRD Asia’s 5-Star Employer of Choice 2024 List

How to prevent the misuse of company benefits in Singapore

Singapore employers warned of losing top talent without strong DEIB strategies